Purpose. Special considerations in the selection of medication inhaler devices for elderly patients with chronic obstructive pulmonary disease (COPD) in the ambulatory care setting are reviewed.

If you need to make a last-minute run to the store to pick up something for your New Year's Eve party, Walmart will be an option for you this year, as the company told USA TODAY their stores ...

Objective To compare the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once daily dry powder inhaler, ...

this eliminates all the guesswork and uncertainty about how much medicine is left in an inhaler. For example, Ventolin HFA, Advair HFA, and fluticasone have dose counters, Some asthma inhalers do not ...

Asthma inhalers are hand-held devices that allow ... MDIs can recognized by the abbreviation HFA (which stands for the propellant hydrofluoroalkane). These include Ventolin HFA, Proventil HFA, Proair ...

No more chlorofluorocarbons, or CFCs, that damage Earth's protective ozone layer. By year's end, all albuterol inhalers must be powered by the more eco-friendly chemical HFA, or hydrofluoroalkane. The ...

Produced by ElevenLabs and News Over Audio (Noa) using AI narration. Listen to more stories on the Noa app. This article was featured in the One Story to Read Today newsletter. Sign up for it here.

Teva had listed nine patents in the Orange Book for its ProAir® HFA albuterol inhaler. Five of the patents were directed to a dose counter used for the delivery device or the canister used to ...

[23] The Federal Circuit noted that “the fact that the FDA approved Teva’s ProAir® HFA combination product as a drug does not make the inhaler’s device parts a drug. They are still devices ...

Amneal beats Teva’s challenge of ruling on some ProAir patents Decision could impact other ‘junk device listings,’ FTC says Five patents related to Teva Pharmaceutical Industries Ltd.’s ProAir HFA ...

ProAir HFA inhaler from the Food and Drug Administration’s Orange Book. Amneal plans to market a generic version of the inhaler and had argued that Teva’s patents were incorrectly included on ...

U.S. District Judge Stanley Chesler agreed with Amneal in June, finding the patents only cover parts of an inhaler device and "do not claim or even mention" ProAir HFA's active ingredient.